Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

In the Prediction of Recurrence and Progression of NMIBC; EORTC or CUETO or Both?

NCT03174912 is registered in ClinicalTrials.gov with Ankara Training and Research Hospital as lead sponsor.

NCT NCT03174912
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03174912 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
In the Prediction of Recurrence and Progression of NMIBC; EORTC or CUETO or Both?
Lead sponsor
Ankara Training and Research Hospital
Phase
Phase 4
Overall status
Completed
Start date
January 1, 2007
Completion date
December 31, 2016
Enrollment
400 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer, disease progression, recurrent bladder cancer